For ORENCIA IV infusion, in order to receive Program benefits, the patient or provider must submit an Explanation of Benefits (EOB) form or a Remittance Advice (RA).Upon expiration, eligible patients may re-enroll using the same card. The Card expires at the end of the calendar year following activation. The Card must be activated before use and includes 13 uses per calendar year.For ORENCIA subcutaneous self-injection, the Co-pay Assistance Card must be presented at the pharmacy, along with a valid prescription for ORENCIA, at the time of purchase.Patients enrolled in co-pay maximizer programs may receive program benefits that vary over time to ensure the program funds are used for the benefit of the patient. A co-pay maximizer program is one in which the amount of the patient’s out-of-pocket costs is adjusted to reflect the availability of support offered by a co-pay support program. Some prescription drug plans have established programs referred to as ‘co-pay maximizer’ programs.Eligible patients with an activated co-pay card and a valid prescription may pay as little as $5 per 30-day supply monthly, annual, and/or per-claim maximum program benefits may apply and vary from patient to patient, depending on the terms of a patient’s prescription drug plan and to ensure that the funds are used for the benefit of the patient, based on factors determined solely by Bristol-Myers Squibb.Patients or their guardian must be 18 years of age or older.Patients must be treated with ORENCIA for an FDA-approved indication.Cash-paying patients are not eligible for co-pay assistance.Patients who move from commercial to federal health insurance will no longer be eligible. Patients who have insurance coverage through a state or federal healthcare program, including Medicare, Medicaid, Medigap, CHAMPUS, Tricare, Veterans Affairs (VA), or Department of Defense (DoD), are not eligible.Co-pay assistance is not available if patient out-of-pocket expenses are $5 or less.
ORENCIA CO PAY CARD PHONE NUMBER FULL
Patients must have commercial insurance that pays for ORENCIA but does not cover the full cost.“There is a huge need to generate more data for all of the drugs that people who are pregnant need to take.” - Christina Chambers, PhD, MPH, Lead Investigator, MotherToBaby Pregnancy StudiesĪre you currently pregnant? Did you take Dupixent® at any point in your current pregnancy? If you answered “yes” to both of these questions, then you have the opportunity to help us learn more about Dupixent® use in pregnancy. MotherToBaby is currently enrolling people who are pregnant in a study examining the use of Dupixent® (dupilumab) to treat moderate-to-severe eczema (atopic dermatitis) or asthma during pregnancy. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy - this is where you come in! In some cases, avoiding or stopping medication use during pregnancy may be more harmful than taking medication. Many people need to take medication during pregnancy to appropriately manage a chronic health condition. Help Us Better Understand the Effects of Dupixent® in Pregnancy
0 kommentar(er)
